参考文献/References:
[1] Hu XM,De Silva TM,Chen J,et al.Cerebral vascular disease and neurovascular injury in ischemic stroke[J].Circ Res,2017,120(3):449-471.
[2] Urdaneta AE,Bhalla P.Cutting edge acute ischemic stroke management[J].Emerg Med Clin North Am,2019,37(3):365-379.
[3] Jarroux J,Morillon A,Pinskaya M.History,discovery,and classification of lncRNAs[J].Adv Exp Med Biol,2017,1008:1-46.
[4] Mccown PJ,Wang MC,Jaeger L,et al.Secondary structural model of human MALAT1 reveals multiple structure-function relationships[J].Int J Mol Sci,2019,20(22):5610.
[5] Guo D,Ma J,Yan L,et al.Down-Regulation of lncrna MALAT1 attenuates neuronal cell death through suppressing beclin1-Dependent autophagy by regulating Mir-30a in cerebral ischemic stroke[J].Cell Physiol Biochem,2017,43(1):182-194.
[6] Ouyang YB,Stary CM,Yang GY,et al.microRNAs: innovative targets for cerebral ischemia and stroke[J].Curr Drug Targets,2013,14(1):90-101.
[7] Campbell BC,Mitchell PJ,Kleinig TJ,et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection[J].N Engl J Med,2015,372(11):1009-1018.
[8] Blakeley JO,Llinas RH.Thrombolytic therapy for acute ischemic stroke[J].J Neurol Sci,2007,261(1/2):55-62.
[9] Li D,Wang C,Yao Y,et al.mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type[J].FASEB J,2016,30(10):3388-3399.
[10] Ginsberg MD.Current status of neuroprotection for cerebral ischemia:synoptic overview[J].Stroke,2009,40(3Suppl):111-114.
[11] Li Z,Yu X,Shen J.ANRIL:a pivotal tumor suppressor long non-coding RNA in human cancers[J].Tumour Biol,2016,37(5):5657-5661.
[12] Zhang X,Hamblin MH,Yin KJ,et al.Noncoding RNAs and stroke[J].Neuroscientist,2019,25(1):22-26.
[13] Lavorgna G,Vago R,Sarmini M,et al.Long noncoding RNAs as novel therapeutic targets in cancer[J].PharmacolRes,2016,110:131-138.
[14] Cabianca DS,Casa V,Gabellini D.A novel molecular mechanism in humangenetic disease:a DNA repeat-derived lncRNA[J].RNA Biol,2012,9(10):1211-1217.
[15] Andersen RE,Lim DA.Forging our understanding of lncRNAs in the brain[J].Cell Tissue Res,2018,371(1):55-71.
[16] Ji P,Diederichs S,Wang WB,et al.MALAT-1, a novel noncoding RNA, and thymosin beta 4 predict metastasis and survival in early-stage non-small cell lung cancer[J].Oncogene,2003,22(39):8031-8041.
[17] Tripathi V,Ellis JD,Shen Z,et al.The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation[J].Mol Cell,2010,39(6):925-938.
[18] Yang F,Yi F,Han X,et al.MALAT-1 interacts with hnRNP C in cell cycle regulation[J].FEBS Lett,2013,587(19):3175-3181.
[19] Xiao H,Tang K,Liu P,et al.LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma[J].Oncotarget,2015,6(35):38005-38015.
[20] Wei Y,Niu B.Role of MALAT1 as a prognostic factor for survival in various cancers: a systematic review of the literature with Meta-Analysis[J].Dis Markers,2015,2015:164635.
[21] Xue YZ,LiZJ,Liu WT,et al.Down-regulation of lncRNA MALAT1 alleviates vascular lesion and vascular remodeling of rats with hypertension[J].Aging,2019,11(14):5192-5205.
[22] Wang L,Liu J,Xie W,et al.Overexpression of MALAT1 relates to lung injury through sponging miR-425 and promoting cell apoptosis during ARDS[J].Can Respir J,2019,2019:1871394.
[23] Yong H,Wu G,Chen J,et al.lncRNA MALAT1 accelerates skeletal muscle cell apoptosis and inflammatory response in sepsis by decreasing BRCA1 expression by recruiting EZH2[J].Mol Ther Nucleic Acids,2019,19:97-108.
[24] Sandoval K,Witt KA.Blood-brain barrier tight junction permeability and ischemic stroke[J].Neurobiol Dis,2008,32(2):200-219.
[25] Date I,Takagi N,Takagi K,et al.Hepatocyte growth factor attenuates cerebral ischemia-induced increase in permeability of the blood-brain barrier and decreases in expression of tight junctional proteins in cerebral vessels[J].Neurosci Lett,2006,407(2):141-145.
[26] Zhang J,Yuan L,Zhang X,et al.Altered long non-coding RNA transcriptomic profiles in brain microvascular endothelium after cerebral ischemia[J].Exp Neurol,2016,277:162-170.
[27] Zhang X,Tang X,Liu,et al.Long noncoding RNA malat1 regulates cerebrovascular pathologies in ischemic stroke[J].J Neurosci,2017,37(7):1797-1806.
[28] Levine B,Kroemer G.Autophagy in the pathogenesis of disease[J].Cell,2008,132(1):27-42.
[29] Roohbakhsh A,Shamsizadeh A,Hayes AW,et al.Melatonin asan endogenous regulator of diseases:the role of autophagy[J].PharmacolRes,2018,133:265-276.
[30] Li Z,Li J,Tang N.Long noncoding RNA Malat1 is a potent autophagy inducer protecting brain microvascular endothelial cells against oxygen-glucose deprivation/reoxygenation-induced injury by sponging miR-26b and upregulating ULK2 expression[J].Neuroscience,2017,354:1-10.
[31] Wang S,Han X,Mao Z,et al.MALAT1 lncRNA induces autophagy and protects brain microvascular endothelial cells against oxygen-glucose deprivation by binding to miR-200c-3p and upregulating SIRT1 expression[J].Neuroscience,2019,397:116-126.
[32] Caporarello N,Lupo G,Olivieri M,et al.Classical VEGF,notch and Ang signalling in cancer angiogenesis,alternative approaches and future directions(review)[J].Mol Med Rep,2017,16(4):4393-4402.
[33] Navarro-Sobrino M,Rosell A,Hernández-Guillamon M,et al.A large screening of angiogenesis biomarkers and their association with neurological outcome after ischemic stroke[J].Atherosclerosis,2011,216(1):205-211.
[34] Wang C,Qu Y,Suo R,et al.Long non-coding RNA MALAT1 regulates angiogenesis following oxygen-glucose deprivation/reoxygenation[J].J Cell Mol Med,2019,23(4):2970-2983.
[35] Ren L,Wei C,Li K,et al.LncRNA MALAT1 up-regulates VEGF-A and ANGPT2 to promote angiogenesis in brain microvascular endothelial cells against oxygen-glucose deprivation via targetting miR-145[J].Biosci Rep,2019,39(3):10.
[36] Zhang T,Wang H,Li Q,et al.MALAT1 activates the P53 signaling pathway by RegulatingMDM2toPromote ischemic stroke[J].Cell Physiol Biochem,2018,50(6):2216-2228.
[37] Cao DW,Liu MM,Duan R,et al.The lncRNA malat1 functions as a ceRNA to contribute to berberine-mediated inhibition of HMGB1 by sponging miR-181c-5p in poststroke inflammation[J].Acta Pharmacol Sin,2020,41(1):22-33.